SAN DIEGO -- Treatment with hydroxyurea led to more hematologic dose-limiting toxicities (DLTs) compared with placebo in ...
Blood is one of the oldest drugs in the world, but after many decades of research, it is still not always clear when a blood ...
Beam Therapeutics (BEAM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Yanan Zhu ...
The majority of SCD patients given Lyfgenia in clinical trials remained free of vaso-occlusive events (VOEs) following ...
Blood disorders are a group of conditions that affect the production, function, or structure of blood cells, leading to ...
Transplant is beneficial earlier in life, Wang told MedPage Today, but carries potential short- and long-term side effects.
"The education was not there. It still isn't there, but it should be," Alvin Henry Jr., a sickle cell disease patient, said. ...
The AURORA study is a randomized, double-blind, placebo-controlled Phase 2 clinical trial that enrolled 75 adult subjects with EPP. Subjects were randomized 1:1:1 to receive 20 mg of bitopertin (n=26) ...
Geron (GERN) announced results from an oral presentation at the 66th American Society of Hematology, or ASH, annual meeting, reporting Phase 1 ...
Blood is one of the oldest drugs in the world, but after many decades of research, it is still not always clear when a blood ...
This year at BuzzFeed, we spotlighted the voices of murderers, kidnapping survivors, and more. Below are some of the most ...